StreetAlpha.app
Home › Stocks › TKNO

Alpha Teknova, Inc. (TKNO)

$7.63
▼ −2.30%
LAST CLOSE · NOV 20

Teknova makes catalog and custom lab reagents and culture media used in drug discovery, development, and diagnostics. It last closed at $7.63 on Nov 20, down 2.30% on the day. The next earnings report for TKNO is expected around Thu, Feb 25, 2027, after the close. For the quarter ended Sep 2026, TKNO reported EPS of -$0.06 on revenue of $12.7M, with revenue up 21.5% from a year ago. Over its last 8 reports the stock moved an average of 7.5% the session after earnings. Over the last 12 months TKNO insiders bought $144K of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is TKNO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TKNO.

Key Stats

Last 12 months
Results
Revenue
$46.0M
+15.4% vs a year ago
Net income
−$16.0M
−34.8% margin
EPS (diluted)
−$0.30
Free cash flow
−$6.4M
−13.9% margin
Valuation
Market cap
$480.0M
62.9M shares
P/E
–
No P/E while losing money
Price to sales
10.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$6.6M
At Sep 30
Debt
$13.3M
At Sep 30
Shareholder equity
$59.8M
Shares outstanding
62.9M
At Nov 4
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $36.9M$36.9MFY2021FY2022: $41.4M$41.4MFY2022FY2023: $36.7M$36.7MFY2023FY2024: $37.7M$37.7MFY2024FY2025: $40.5M$40.5MFY2025

From TKNO's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 25
Estimated date · After the close
Reported EPS
-$0.06
Quarter ended Sep 2026
Year ago EPS
-$0.08
Same quarter last year
Revenue
$12.7M
+21.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.10Dec '24Mar 2025: -$0.09Mar '25Jun 2025: -$0.07Jun '25Sep 2025: -$0.08Sep '25Dec 2025: -$0.09Dec '25Mar 2026: -$0.08Mar '26Jun 2026: -$0.06Jun '26Sep 2026: -$0.06Sep '26Latest -$0.06
Revenue by quarter
Dec 2024: $9.3MDec '24Mar 2025: $9.8MMar '25Jun 2025: $10.3MJun '25Sep 2025: $10.5MSep '25Dec 2025: $10.0MDec '25Mar 2026: $11.1MMar '26Jun 2026: $12.2MJun '26Sep 2026: $12.7MSep '26Latest $12.7M
How TKNO moved after its last 8 reports
Average move the session after a report ±7.5%
Oct 21, 2026After the close+5.1%
Aug 5, 2026After the close+16.4%
May 6, 2026After the close+9.9%
Feb 26, 2026After the close+13.2%
Nov 6, 2025After the close−2.1%
Aug 7, 2025After the close−2.5%
May 8, 2025After the close+9.3%
Mar 4, 2025After the close−1.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on TKNOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on TKNO
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on TKNO

Technical Analysis

TKNO · as of the Nov 20 close · updated each morning
Moving sideways

The stock is 2% below its 20 day and 4% below its 50 day average. It is 31% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 48). The nearest support is the Pivot S1 at $7.50, and the nearest resistance the swing high (Sep 2) at $7.64.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 7.7%/day
Key levels
$9.4852 week high+24.2%
$7.9450 day average+4.1%
$7.7820 day average+2.0%
$7.78Pivot R1+2.0%
$7.65Pivot+0.3%
$7.64Swing high (Sep 2)+0.1%
$7.63Last close
$7.50Pivot S1−1.7%
$7.08100 day average−7.2%
$6.88Swing low (Nov 4)−9.8%
$5.26200 day average−31.1%
$1.9152 week low−75.0%
Indicators
RSI (14)47.69Middle of its rangeNeutral
MACD0.06Below its signal lineBearish
Stochastic36.3Middle of its rangeNeutral
ADX (14)15.1No clear trend
Williams %R-69.5Oversold below −80, overbought above −20Neutral
CCI (20)-17.6Oversold below −100, overbought above 100Neutral
Rate of change−2.3%Change over 10 sessionsBearish
ATR (14)$0.59Typical daily range, 7.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for TKNO

What happened before

See how TKNO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow TKNO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How TKNO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for TKNOHow many large options trades hit TKNO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

TKNO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲69 buying vs 24 selling
  • ▲Held by funds +2.3 pts
  • ▲Funds holding +30
  • ▲Superinvestors: 4 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding11080+37.5%
In funds' top 1001−100.0%
Held by funds16.8%14.5%+2.3 pts
New / increased34 / 3512 / 35+46.8%
Reduced / sold out20 / 419 / 8−11.1%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TKNO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

TKNO Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$144K2 buys · 2 insiders
Sold$00 sales · 0 insiders
Cluster buy: 2 insiders bought $144K between Mar 6 and Mar 6.
2026-03 bought $144KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Mar 6Matthew LowellCFOBuy40,000$2.19$88K
Mar 6Stephen GunstreamPresident and CEOBuy26,000$2.15$56K
Jun 27, 2025Martha J DemskiDirectorSale plan8,000$5.06$40K
Every insider buy and sale for TKNO over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See TKNO insider trades →

From SEC Form 4 filings by TKNO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TKNO is in one of them and how their past TKNO trades turned out.

TKNO in the AI portfolios
Loading…

TKNO News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TKNO in an article yet. Here's the latest on the wider market.

TKNO in the news

About Alpha Teknova

Teknova makes specialty chemical formulations and culture materials used in biological research, drug discovery, and diagnostics. Its products include pre-poured media plates, liquid microbial culture media and supplements, and molecular biology reagents, offered as both standard catalog items and custom formulations. Customers include pharmaceutical and biotechnology companies, contract manufacturers, diagnostic makers, and academic and government research institutions. The company is based in Hollister, California, where it manufactures its products.

Headquarters
Hollister, CA